MSLN and ovarian carcinoma: Our studies show that as an independent prognostic factor of ovarian cancer, MSLN participates in a variety of pathways related to suppressing immune activation and promoting chemotherapy resistance, which may provide a new perspective for immunotherapy of ovarian cancer.